<p>Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study</p>-Reference-Cited by-同舟云学术

Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study

Published:2020-09 Issue: Volume:Volume 12 Page:9183-9195
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Huang Qizhen,Lin Kongying^ORCID,Wang Lei^ORCID,Zeng Jianxing,Liu Hongzhi,Ding Zongren,Zeng Yongyi,Liu Jingfeng^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference32 articles.

1. 42,573 cases of hepatectomy in China: a multicenter retrospective investigation

2. Clinical Characteristics and Surgical Prognosis of Hepatocellular Carcinoma with Bile Duct Invasion

3. Hepatocellular carcinoma with biliary tumor thrombi: Aggressive operative approach after appropriate preoperative management

4. Prognosis of hepatocellular carcinoma with bile duct tumor thrombus after R0 resection: a matched study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DEB‐TACE versus cTACE for unresectable HCC with B1‐type bile duct invasion after successful biliary drainage: A propensity score matching analysis;Cancer Medicine;2024-07

2. Surgical management for hepatocellular carcinoma with concurrent portal vein tumour thrombus and bile duct tumour thrombus: a case report;Annals of Medicine & Surgery;2024-04-24

3. Therapeutic effect of postoperative adjuvant transcatheter arterial chemoembolization based on the neutrophil-to-lymphocyte ratio;Frontiers in Surgery;2023-01-06

4. Recurrence hazard rate in patients with hepatocellular carcinoma and bile duct tumor thrombus: a multicenter observational study;HPB;2022-10

5. Prognostic Comparison Between Liver Resection and Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Patients With Bile Duct Tumor Thrombus: A Propensity-Score Matching Analysis;Frontiers in Oncology;2022-03-15